NasdaqGS:ARWRBiotechs
Is Arrowhead Pharmaceuticals (ARWR) Pricing Reflect Recent RNAi Progress And Strong Share Price Gains?
If you are looking at Arrowhead Pharmaceuticals and wondering whether the recent excitement matches the stock's underlying value, this article will walk you through the key signals to watch.
The share price sits at US$72.14 after returns of 7.8% over the past week, 6.4% over the past month, 6.4% year to date, 266.6% over the past year and 114.6% over three years, while the five year return is negative at 19.7%.
Recent coverage around Arrowhead has focused on its progress in RNA interference...